View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
Butterworth Laboratories|15 December 2014

Elemental Impurity Analysis in Pharmaceuticals

A method to identify heavy metals in pharmaceuticals was introduced in the United States Pharmacopoeia more than 100 years ago.

A method to identify heavy metals in pharmaceuticals was introduced in the United States Pharmacopoeia more than 100 years ago.

Pharmaceutical companies are still using the same method, the USP Heavy Metals Limit Test.

The current colorimetric methodology is intended to control metals, which form a sulfide precipitate, such as lead and copper.

These metals are potential contaminants from water pipes, manufacturing equipment and processes.

Risk factors for metal contamination have changed dramatically, for example with the use of metal catalysts, yet standards for their control have changed little in more than 50 years.

The method is no longer fit for purpose and most heavy metal limits currently in place hold little basis in toxicology.

International Pharmaceutical Excipients Council (IPEC) Americas, state they are unaware of any known metal impurity issues impacting patient safety, although they agree on the need to enhance future testing.

However, harmonisation of pharmacopoeia methods made slow progress in the past.

One of the most discussed topics currently affecting good manufacturing practices (GMP) laboratories, data integrity involves conforming to fundamental elements of quality: attributable, legible, contemporaneous,...
At Butterworth Laboratories Ltd we understand the importance of keeping up with changes in the Pharmacopoeias and ensuring their implementation. A revision of USP, Residual...
Run by scientists, for scientists.
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology